首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis of sterically encumbered 11β-aminoprogesterone derivatives and evaluation as 11β-hydroxysteroid dehydrogenase inhibitors and mineralocorticoid receptor antagonists
【24h】

Synthesis of sterically encumbered 11β-aminoprogesterone derivatives and evaluation as 11β-hydroxysteroid dehydrogenase inhibitors and mineralocorticoid receptor antagonists

机译:位阻型11β-氨基孕酮衍生物的合成及其作为11β-羟基类固醇脱氢酶抑制剂和盐皮质激素受体拮抗剂的评价

获取原文
获取原文并翻译 | 示例
           

摘要

11β-Hydroxyprogesterone is a well-known nonselective inhibitor of 11β-hydroxysteroid dehydrogenase (11βHSD) types 1 and 2. It also activates the mineralocorticoid receptor (MR). Modulation of corticosteroid action by inhibition of 11βHSDs or blocking MR is currently under consideration for treatment of electrolyte disturbances, metabolic diseases and chronic inflammatory disorders. We established conditions to synthesize sterically demanding 11β-aminoprogesterone, which following subsequent nucleophilic or reductive amination, allowed extension of the amino group to prepare amino acid derivatives. Biological testing revealed that some of the 11β-aminoprogesterone derivatives selectively inhibit 11βHSD2. Moreover, two compounds that did not significantly inhibit 11βHSDs had antagonist properties on MR. The 11β-aminoprogesterone derivatives form a basis for the further development of improved modulators of corticosteroid action.
机译:11β-羟基孕酮是一种众所周知的1和2型11β-羟基类固醇脱氢酶(11βHSD)的非选择性抑制剂。它还激活盐皮质激素受体(MR)。目前正在考虑通过抑制11βHSD或阻断MR来调节糖皮质激素的作用,以治疗电解质紊乱,代谢性疾病和慢性炎症性疾病。我们建立了合成立体上需要的11β-氨基孕酮的条件,随后进行亲核或还原性胺化反应后,可以扩展氨基基团来制备氨基酸衍生物。生物测试表明,某些11β-氨基孕酮衍生物选择性抑制11βHSD2。此外,没有明显抑制11βHSD的两种化合物对MR具有拮抗作用。 11β-氨基孕酮衍生物构成了进一步开发皮质类固醇作用的调节剂的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号